Found 7 matching trials
Nerve Growth Factor for the Treatment of Cornea Disease
N/ATo determine the efficacy and safety of nerve growth factor in the treatmen...
Location
Stanford University
DEFENDO Long Term Follow-up Study in Stage 1 NK Patients
N/APrimary Objective
To evaluate the long-term safety and efficacy (healing) ...
Location
New Vision Institute
Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis
PHASE4Primary Objective:
To assess the efficacy of cenegermin-bkbj (20 mcg/mL) o...
Location
Multiple Locations
DOMPE -MT Neurotrophic Keratitis
PHASE4TITLE: Toyos Clinic / A Phase 4 Study to Assess Longer Duration of Treatmen...
Status
Active Not Recruiting
Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis
PHASE4This study is to evaluate the safety and efficacy of OXERVATE® 0.002% (20 m...
OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate
N/ANeurotrophic keratitis (NK) is a condition where the cornea, or clear outer...
NGF Treatment for Patients With Neuropathic Corneal Pain
PHASE1This prospective, single center, interventional, open-label, single arm, no...
Location
Tufts Medical Center